Equities

Global Health Ltd

MEDANTA:NSI

Global Health Ltd

Actions
Health CareHealth Care Providers
  • Price (INR)1,404.10
  • Today's Change-17.10 / -1.20%
  • Shares traded28.83k
  • 1 Year change+148.01%
  • Beta--
Data delayed at least 15 minutes, as of May 18 2024 08:11 BST.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Profile data is unavailable for this security.

About the company

Global Health Limited (Medanta) is an India-based multi-specialty tertiary care provider in the North and East regions of India. Medanta delivers advanced, end-to-end healthcare in Delhi, Gurugram, Indore, Ranchi, Patna, and Lucknow through its network of five hospitals, six Mediclinic, diagnostic laboratories, homecare, and telemedicine services. It provides treatments for coronary artery disease, head and neck cancer, acute myeloid leukemia, epilepsy, hip fracture, Parkinson's disease, refractive error, prostate cancer, chronic kidney disease, cerebral stroke, sepsis, liver cirrhosis, rheumatoid, arthritis, hypertension, diabetes, bronchial asthma, stomach cancer, and chronic otitis media. Medanta specializes in cardiac surgery, nephrology, urology, andrology, dermatology, ophthalmology, radiology and imaging, dental sciences, and interventional cardiology, among others. Its facilities and services include medicine delivery, lab tests & diagnostics, book homecare services and others.

  • Revenue in INR (TTM)31.53bn
  • Net income in INR4.52bn
  • Incorporated2004
  • Employees9.35k
  • Location
    Global Health LtdE-18, Defence ColonyNEW DELHI 110024IndiaIND
  • Phone+91 1 244834060
  • Websitehttps://www.medanta.org/
More ▼

Peer analysis

Key Information
CompanyRevenue (TTM)Net income (TTM)Market capEmployeesPrice/earnings (TTM)Price/book value (MRQ)Price/cash flow (TTM)Price/sales (TTM)EPS (excl. extraordinary items, TTM)EPS (incl. extraordinary items, TTM)Revenue per share (TTM)Book value per share (MRQ)Asset turnover (TTM)Inventory turnover (TTM)Receivables turnover (TTM)Revenues per employee (TTM)Return on avg assets (TTM)Return on avg assets (5 yr avg)Return on investment (TTM)Return on investment (5 yr avg)Gross margin (TTM)Gross margin
(5 yr avg)
Net profit margin (TTM)Net Profit margin
(5 yr avg)
Quick ratio (MRQ)Interest coverage (TTM)Total debt to capital (MRQ)Payout ratio
(5 yr avg)
Revenue
(YOY change %)
Revenue
(5 yr growth rate)
Net income
(YOY change %)
Net income
(5 yr growth rate)
Capital expenditure
(5 yr growth rate)
Dividend
(5 yr growth rate)
Global Health Ltd31.53bn4.52bn381.60bn9.35k84.51--61.8512.1016.8216.82117.34--------3,372,195.00--------76.84--14.33----7.89----24.35--66.20------
Data as of May 18 2024. Currency figures normalised to Global Health Ltd's reporting currency: Indian Rupee INR

Institutional shareholders

13.02%Per cent of shares held by top holders
HolderShares% Held
Norges Bank Investment Managementas of 31 Dec 20238.76m3.26%
Polar Capital LLPas of 29 Feb 20243.78m1.41%
Canara Robeco Asset Management Co. Ltd.as of 30 Apr 20243.77m1.40%
Invesco Asset Management (India) Pvt Ltd.as of 30 Apr 20243.73m1.39%
HDFC Asset Management Co. Ltd. (Invt Mgmt)as of 30 Apr 20243.69m1.38%
The Vanguard Group, Inc.as of 09 May 20242.75m1.02%
Axis Asset Management Co. Ltd.as of 30 Apr 20242.48m0.93%
Motilal Oswal Asset Management Co. Ltd.as of 30 Apr 20242.20m0.82%
Kotak Mahindra Asset Management Co. Ltd.as of 30 Apr 20242.18m0.81%
HSBC Asset Management (India) Pvt Ltd.as of 30 Apr 20241.62m0.60%
More ▼
Data from 31 Dec 2023 - 15 May 2024Source: FactSet Research Systems Inc.
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.